Related Experiment Video
Updated: May 19, 2026
12:24
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
[Hepatocellular carcinoma - long-term treatable disease]
1Onkologicke a radioterapeuticke oddeleni FN a LF UK v Plzni, Plzen. finek@fnplzen.cz
Summary
This case report details a patient with unresectable hepatocellular carcinoma who survived for 30 months after treatment with sorafenib. This demonstrates the potential efficacy of sorafenib in managing advanced liver cancer.
Area of Science:
- Hepatocellular carcinoma research
- Oncology
- Pharmacological treatments for liver cancer
Background:
- Hepatocellular carcinoma (HCC) is a primary liver cancer with poor prognosis, especially when unresectable.
- Sorafenib is a targeted therapy drug used in advanced HCC treatment.
Observation:
- A patient with unresectable HCC was treated with sorafenib.
- The patient achieved a survival of 30 months.
Findings:
- Sorafenib treatment in this case resulted in a 30-month survival period for a patient with unresectable HCC.
- This outcome suggests a potential benefit of sorafenib in extending survival for advanced liver cancer patients.
Implications:
- This case highlights sorafenib as a viable treatment option for unresectable HCC.
- Further research into sorafenib's long-term efficacy in HCC management is warranted.
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...